A novel organotypic dento-epithelial culture model: Effect of fusobacterium nucleatum biofilm on B-defensin-2, -3, and LL-37 expression

Journal of Periodontology

Volumn 83, Issue 2, 2012, Pages 242-247

  Gursoy, Ulvi K ^a,b   Pöllänen, Marja ^a   Könönen, Eija ^a,b   Uitto, Veli Jukka ^c  

^a UNIVERSITY OF TURKU   (Finland)

^b NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

^c UNIVERSITY OF HELSINKI   (Finland)

Author keywords

Beta defensin 2; Beta defensin 3; Epithelium; Fusobacterium nucleatum; Human; LL 37 peptide

Indexed keywords

ANTIMICROBIAL CATIONIC PEPTIDE; BETA DEFENSIN; BETA DEFENSIN 3, HUMAN; BETA-DEFENSIN 3, HUMAN; CAP18 LIPOPOLYSACCHARIDE BINDING PROTEIN; CAP18 LIPOPOLYSACCHARIDE-BINDING PROTEIN; DEFB4A PROTEIN, HUMAN;

ARTICLE; BIOFILM; BIOSYNTHESIS; COCULTURE; CYTOLOGY; EPITHELIUM; FUSOBACTERIUM NUCLEATUM; GROWTH, DEVELOPMENT AND AGING; HUMAN; METABOLISM; ORGAN CULTURE TECHNIQUE; PHYSIOLOGY; TOOTH;

ANTIMICROBIAL CATIONIC PEPTIDES; BETA-DEFENSINS; BIOFILMS; COCULTURE TECHNIQUES; EPITHELIUM; FUSOBACTERIUM NUCLEATUM; HUMANS; ORGAN CULTURE TECHNIQUES; TOOTH;

EID: 84856645767     PISSN: 00223492     EISSN: None     Source Type: Journal    
DOI: 10.1902/jop.2011.110177     Document Type: Article

References (31)

1. Pöllänen MT, Salonen JI, Uitto VJ. Structure and function of the tooth-epithelial interface in health and disease. Periodontol 2000 2003;31:12-31. (Pubitemid 37487407)
2. Wertz PW, Squier CA. Cellular and molecular basis of barrier function in oral epithelium. Crit Rev Ther Drug Carrier Syst 1991;8:237-269.
3. Dale BA. Periodontal epithelium: A newly recognized role in health and disease. Periodontol 2000 2002;30:70-78.
4. ChungWO, Dommisch H, Yin L, Dale BA. Expression of defensins in gingiva and their role in periodontal health and disease. Curr Pharm Des 2007;13:3073-3083. (Pubitemid 350130959)
5. Diamond G, Ryan LK. Beta-defensins: What are they REALLY doing in the oral cavity? Oral Dis 2011;17: 628-635.
6. Ganz T. Defensins: Antimicrobial peptides of innate immunity. Nat Rev Immunol 2003;3:710-720. (Pubitemid 41070812)
7. Yin L, Chino T, Horst OV, et al. Differential and coordinated expression of defensins and cytokines by gingival epithelial cells and dendritic cells in response to oral bacteria. BMC Immunol 2010;11:37.
8. Dale BA, Krisanaprakornkit S. Defensin antimicrobial peptides in the oral cavity. J Oral Pathol Med 2001;30: 321-327. (Pubitemid 32620844)
9. Zanetti M, Gennaro R, Scocchi M, Skerlavaj B. Structure and biology of cathelicidins. Adv Exp Med Biol 2000;479:203-218. (Pubitemid 32193310)
10. Nizet V, Ohtake T, Lauth X, et al. Innate antimicrobial peptide protects the skin from invasive bacterial infection. Nature 2001;414:454-457. (Pubitemid 34173727)
11. Dale BA, Kimball JR, Krisanaprakornkit S, et al. Localized antimicrobial peptide expression in human gingiva. J Periodontal Res 2001;36:285-294. (Pubitemid 33641093)
12. Lu Q, Samaranayake LP, Darveau RP, Jin L. Expression of human b-defensin-3 in gingival epithelia. J Periodontal Res 2005;40:474-481. (Pubitemid 41673752)
13. Kolenbrander PE, Andersen RN, Blehert DS, Egland PG, Foster JS, Palmer RJ Jr. Communication among oral bacteria. Microbiol Mol Biol Rev 2002;66:486-505. (Pubitemid 35001141)
14. Gursoy UK, Könönen E, Uitto VJ. Intracellular replication of fusobacteria requires new actin filament formation of epithelial cells. APMIS 2008;116:1063-1070.
15. Gursoy UK, Könönen E, Uitto VJ. Stimulation of epithelial cell matrix metalloproteinase (MMP-2, -9, -13) and interleukin-8 secretion by fusobacteria. Oral Microbiol Immunol 2008;23:432-434.
16. Oksanen J, Hormia M. An organotypic in vitro model that mimics the dento-epithelial junction. J Periodontol 2002;73:86-93. (Pubitemid 34213463)
17. Merritt JH, Kadouri DE, O'Toole GA. Growing and analyzing static biofilms. Curr Protoc Microbiol 2005; 1B:1.7-1.9.
18. Gursoy UK, Pöllänen M, Könönen E, Uitto VJ. Biofilm formation enhances the oxygen tolerance and invasiveness of Fusobacterium nucleatum in an oral mucosa culture model. J Periodontol 2010;81:1084-1091.
19. Merne M, Syrjänen S. The mesenchymal substrate influences the epithelial phenotype in a three-dimensional cell culture. Arch Dermatol Res 2003;295: 190-198. (Pubitemid 37211199)
20. Pritlove-Carson S, Charlesworth S, Morgan PR, Palmer RM. Cytokeratin phenotypes at the dento-gingival junction in relative health and inflammation, in smokers and nonsmokers. Oral Dis 1997;3:19-24. (Pubitemid 27220798)
21. Abiko Y, Saitoh M, Nishimura M, Yamazaki M, Sawamura D, Kaku T. Role of b-defensins in oral epithelial health and disease. Med Mol Morphol 2007;40: 179-184. (Pubitemid 350277687)
22. Krisanaprakornkit S, Kimball JR, Weinberg A, Darveau RP, Bainbridge BW, Dale BA. Inducible expression of human b-defensin 2 by Fusobacterium nucleatum in oral epithelial cells: Multiple signaling pathways and role of commensal bacteria in innate immunity and the epithelial barrier. Infect Immun 2000;68:2907-2915. (Pubitemid 30253871)
23. Dunsche A, Acxil Y, Siebert R, Harder J, Schröder J-M, Jepsen S. Expression profile of human defensins and antimicrobial proteins in oral tissues. J Oral Pathol Med 2001;30:154-158. (Pubitemid 32139986)
24. Gomes P de S, Fernandes MH. Defensins in the oral cavity: Distribution and biological role. J Oral Pathol Med 2010;39:1-9.
25. Liu L, Wang L, Jia HP, et al. Structure and mapping of the human b-defensin HBD-2 gene and its expression at sites of inflammation. Gene 1998;222: 237-244. (Pubitemid 29003118)
26. Nishimura E, Kato M, Hashizume S. Human b-defensin- 2 induction in human keratinocyte by synergistic stimulation with foods and Esherichia coli. Cytotechnology 2003;43:135-144. (Pubitemid 41184375)
27. Brancatisano FL, Maisetta G, Barsotti F, et al. Reduced human beta defensin 3 in individuals with periodontal disease. J Dent Res 2011;90:241-245.
28. Semple F, Webb S, Li H-N, et al. Human b-defensin 3 has immunosuppressive activity in vitro and in vivo. Eur J Immunol 2010;40:1073-1078.
29. Türkoǧlu O, Kandiloǧlu G, Berdeli A, Emingil G, Atilla G. Antimicrobial peptide hCAP-18/LL-37 protein and mRNA expressions in different periodontal diseases. Oral Dis 2011;17:60-67.
30. Inomata M, Into T, Murakami Y. Suppressive effect of the antimicrobial peptide LL-37 on expression of IL-6, IL-8 and CXCL10 induced by Porphyromonas gingivalis cells and extracts in human gingival fibroblasts. Eur J Oral Sci 2010;118:574-581.
31. Byfield FJ, Wen Q, Leszczynska K, et al. Cathelicidin LL-37 peptide regulates endothelial cell stiffness and endothelial barrier permeability. Am J Physiol Cell Physiol 2011;300:C105-C112.